CN Patent

CN106432042A — 尼达尼布乙磺酸水合物的药物新晶型

Assigned to Nanjing Huawe Medicine Technology Development Co Ltd · Expires 2017-02-22 · 9y expired

What this patent protects

本发明的尼达尼布乙磺酸盐一水合物晶型A采用Rigaku Smartlab-3型X-射线衍射仪，在CuK-beta、40KV、30mA测定条件下测得的X-射线衍射图具有包括在衍射角2θ：11.554度、17.423度、18.800度、19.683度、19.986度的衍射峰，2θ误差为0.2度。本发明人提供的尼达尼布乙磺酸盐一水合物的晶型制备工艺简单、纯度较高且稳定性较好。

USPTO Abstract

本发明的尼达尼布乙磺酸盐一水合物晶型A采用Rigaku Smartlab-3型X-射线衍射仪，在CuK-beta、40KV、30mA测定条件下测得的X-射线衍射图具有包括在衍射角2θ：11.554度、17.423度、18.800度、19.683度、19.986度的衍射峰，2θ误差为0.2度。本发明人提供的尼达尼布乙磺酸盐一水合物的晶型制备工艺简单、纯度较高且稳定性较好。

Drugs covered by this patent

Patent Metadata

Patent number
CN106432042A
Jurisdiction
CN
Classification
—
Expires
2017-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Huawe Medicine Technology Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.